Missouriwatcher
Editor, Senior Moderator
July 28, 2011 - Finemost Corporation dba Qualiherb, 13839 Bentley Place, Cerritos, CA 90703 announced today that it is conducting a voluntary nationwide recall of the company?s dietary supplements sold under the brand name Qualiherb specific to the following Lot Numbers:
Item No. Products Mfg. No.
20217 Shi Shen Tang Mahuang & Cimicifuga Combination CP10217
20802 Ding Chuan Tang Mahuang & Ginkgo Combination 2008-12
21022 Shen Mi Tang Mahuang & Magnolia Combination CP11022
22101 Xu Ming Tang Mahuang & Ginseng Combination P122101
Qualiherb is conducting a voluntary recall after being notified by representatives of the US Food and Drug Administration (FDA) that lab analysis by FDA of the Shi ShenTang, Shen Mi Tang, and Xu Ming Tang samples found the products contain the presence of ephedrine alkaloids.
FDA has concluded that dietary supplements containing ephedrine alkaloids pose a risk of serious adverse events including heart attack, stroke, and death and that these risks are unreasonable in light of any benefits that may result from the use of these products under their labeled conditions of use or under ordinary conditions of use if the labeling is silent...
http://www.fda.gov/Safety/Recalls/ucm265881.htm
Item No. Products Mfg. No.
20217 Shi Shen Tang Mahuang & Cimicifuga Combination CP10217
20802 Ding Chuan Tang Mahuang & Ginkgo Combination 2008-12
21022 Shen Mi Tang Mahuang & Magnolia Combination CP11022
22101 Xu Ming Tang Mahuang & Ginseng Combination P122101
Qualiherb is conducting a voluntary recall after being notified by representatives of the US Food and Drug Administration (FDA) that lab analysis by FDA of the Shi ShenTang, Shen Mi Tang, and Xu Ming Tang samples found the products contain the presence of ephedrine alkaloids.
FDA has concluded that dietary supplements containing ephedrine alkaloids pose a risk of serious adverse events including heart attack, stroke, and death and that these risks are unreasonable in light of any benefits that may result from the use of these products under their labeled conditions of use or under ordinary conditions of use if the labeling is silent...
http://www.fda.gov/Safety/Recalls/ucm265881.htm